Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

NCT02531880 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

NIH

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Mangafodipir

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)